Cargando…
Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin
Oestrogen receptor alpha (ERα) is a well-known target of endocrine therapy for ERα-positive breast cancer. ERα-negative cells, which are enriched during endocrine therapy, are associated with metastatic relapse. Here we determine that loss of ERα in the invasive front and in lymph node metastasis in...
Autores principales: | Gao, Yuan, Wang, Zhaowei, Hao, Qiang, Li, Weina, Xu, Yujin, Zhang, Juliang, Zhang, Wangqian, Wang, Shuning, Liu, Shuo, Li, Meng, Xue, Xiaochang, Zhang, Wei, Zhang, Cun, Zhang, Yingqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344302/ https://www.ncbi.nlm.nih.gov/pubmed/28266545 http://dx.doi.org/10.1038/ncomms14483 |
Ejemplares similares
-
Genome-Wide Investigation of Genes Regulated by ERα in Breast Cancer Cells
por: Wang, Shuning, et al.
Publicado: (2018) -
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
por: Li, Xiaoju, et al.
Publicado: (2018) -
FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
por: Liu, Chenlin, et al.
Publicado: (2021) -
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer
por: Gao, Yuan, et al.
Publicado: (2018) -
FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells
por: Liu, Shuo, et al.
Publicado: (2017)